HOME >> MEDICINE >> NEWS
Docetaxel versus paclitaxel in breast cancer Results of worlds first head to head trial

Copenhagen, Denmark: Eagerly awaited results from the world's first head to head trial between the anti-cancer drugs docetaxel (Taxotere) and paclitaxel (Taxol)[1] have shown that there was a better overall response rate and longer overall survival among breast cancer patients given docetaxel although docetaxel was associated with more severe side effects.

The new results were presented for the first time today (Wednesday 24 September) at ECCO 12 The European Cancer Conference taking place in Copenhagen.

Four hundred and forty nine women with advanced incurable breast cancer who had received previous treatment with an anthracycline-based chemotherapy were randomised into the Phase III trial from multiple centres across the USA between 1994 and 20012. Half were treated with paclitaxel and half were treated with docetaxel.

The trial's principal investigator, Professor Peter Ravdin, associate professor in the Department of Medicine at the University of Texas Health Science Center in San Antonio, told a news briefing that the women treated with docetaxel survived for a median 15.4 months compared with a median 12.7 months for the women who received paclitaxel.

There was an overall response rate of nearly a third among the docetaxel patients compared with a quarter for the paclitaxel patients. The median time before the breast cancer progressed (TTP) was 5.7 months for the docetaxel patients and 3.6 months for the paclitaxel patients. The results for overall survival and for TTP were statistically significantly superior for docetaxel and the overall response rate in favour of docetaxel approached statistical significance.

However, the women who received docetaxel did experience more severe side effects (grade 3/4 toxicities) with higher incidences of neutropenia (reduction in infection-fighting white blood cells), asthenia (loss of strength), infection, oedema (abnormal accumulation of fluid), mouth ulcers and neuromotor and n
'"/>

Contact: Margaret Willson
m.willson@mwcommunications.org.uk
45-3252-4163
Federation of European Cancer Societies
24-Sep-2003


Page: 1 2

Related medicine news :

1. Good intentions versus bad habits: Why the old ways win out
2. Normal aging versus Alzheimers disease and the potential for prevention
3. Regulatory T cells keep graft-versus-host disease in check
4. Study evaluates Abacavir, Lamivudine and Efavirenz versus Zidovudine, Lamivudine and Efavirenz
5. U-M study finds new target in war against graft-versus-host disease
6. Weekly Taxol (paclitaxel) plus Paraplatin (carboplatin) is safe and effective in patients with advanced lung cancer
7. International breast cancer prevention study launches in the United States and Canada
8. Unexpected benefit seen in treating HER-2 breast cancer with new preoperative drug combo
9. Risk of cardiac death after radiotherapy for breast cancer has declined, study finds
10. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
11. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women

Post Your Comments:
(Date:4/24/2015)... Insuranceautoquote.info has released a new blog ... . , Lowering auto insurance prices is not ... find better offers for their financial budget. Comparing prices ... not require any registration. , Comparing quotes can ... multiple agencies that sell coverage and this means that ...
(Date:4/24/2015)... MMJ Physician Practice in Salem, ... to enroll in the Massachusetts medical marijuana program.    Their ... away from Alternative Therapies Group (ATG), the first ... summer. With the dispensary nearby, MMJ Physician ... for residents of eastern Massachusetts to enroll in ...
(Date:4/24/2015)... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... are used worldwide, and how they would not be necessary ... that the nations have been trained to build up armed ... the confusion and distrust. , “The nations believe they ... compliance, unjust rules and laws, and the rape of their ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 E-Factor Diet claims ... energy high, reduces stress and allows people to enjoy food ... the attention of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative review. ... is the exact blueprint that Jared used to lose weight, ... it works is included inside. This is a diet for ...
(Date:4/24/2015)... A group of Southern Americans will take advantage ... of young Chinese for two weeks from July 21 to ... Chinese will be challenged to avoid conflicts due to cultural ... to be required to function as one team, living and ... Chinese language and Kung Fu martial arts as a part ...
Breaking Medicine News(10 mins):Health News:Car Insurance Quotes Can Help Drivers Lower Their Premiums 2Health News:Medical Doctor from Salem Massachusetts Supports the Medical Marijuana Industry 2Health News:Armed Forces Would Not Be Necessary if Biblical Laws Were Followed, Says Yisrayl Hawkins in New Article 2Health News:E-Factor Diet: Review Examining John Rowley’s Brand New Weight Loss Program Released 2Health News:Inside China: Americans Travel to Heartland of China to Live & Learn with Local Chinese 2Health News:Inside China: Americans Travel to Heartland of China to Live & Learn with Local Chinese 3
(Date:4/24/2015)... , April 24, 2015 Hospira, Inc. ... the development of biosimilar therapies, spoke about the importance ... the European Generics Association (EGA) annual European Biosimilars Group ... The company also announced the publication of a pivotal ... achieving the full promise of biosimilars." ...
(Date:4/23/2015)... Calif., April 23, 2015  Edwards Lifesciences Corporation (NYSE: ... heart valves and hemodynamic monitoring, today reported net income ... or $1.12 per diluted share.  Net income for the ... $0.56 per diluted share, and non-GAAP net income was ... Net sales for the quarter ended March 31, 2015 increased ...
(Date:4/23/2015)... 23, 2015  Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... first quarter financial results on Thursday, May 7, 2015, ... will host a live audio webcast immediately following the ... first quarter 2015 financial results and provide a business ... the live audio webcast via the Investors & Media ...
Breaking Medicine Technology:Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 3Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 5Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 6Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 7Edwards Lifesciences Reports First Quarter Results 2Edwards Lifesciences Reports First Quarter Results 3Edwards Lifesciences Reports First Quarter Results 4Edwards Lifesciences Reports First Quarter Results 5Edwards Lifesciences Reports First Quarter Results 6Edwards Lifesciences Reports First Quarter Results 7Edwards Lifesciences Reports First Quarter Results 8Edwards Lifesciences Reports First Quarter Results 9Edwards Lifesciences Reports First Quarter Results 10Edwards Lifesciences Reports First Quarter Results 11Edwards Lifesciences Reports First Quarter Results 12Edwards Lifesciences Reports First Quarter Results 13Edwards Lifesciences Reports First Quarter Results 14Edwards Lifesciences Reports First Quarter Results 15Edwards Lifesciences Reports First Quarter Results 16Jazz Pharmaceuticals to Report 2015 First Quarter Financial Results on May 7, 2015 2
Cached News: